title: Suppressed bone induction by follistatin in spontaneously hypercholesterolemic rat bone.
abstract: Bone inducing activity in demineralized bone matrix (DBM) of young spontaneously hypercholesterolemic (SHC) rats has been shown to be lower than that of aged SHC rats. This study examined the involvement of bone follistatin, an activin-binding protein, in bone induction. Immunoreactive follistatin was higher in DBM from 10-week-old SHC rats (DBM-10wk) than in DBM from 6-month-old SHC rats (DBM-6mo). When DBM without follistatin supplement was implanted, the C-propeptide of type II procollagen and calcium contents on day 12 in implants of DBM-6mo were 68% and 40% higher than those of DBM-10wk, respectively. In contrast, follistatin supplement to DBM decreased C-propeptide of type II procollagen and calcium contents in implants of both DBM-10wk and DBM-6mo, and the levels of these parameters were comparable between DBM-10wk and DBM-6mo, indicating reduced formation of cartilage and bone. These findings suggest that 1) follistatin content in bone matrix decreases with advancing age in SHC rats, and 2) the follistatin interferes with endochondral bone formation. We demonstrate that the lower bone induction of DBM from young SHC rats was partly due to the abundance of follistatin in bone matrix.
authors.affiliation: Torii Nutrient-Stasis Project, ERATO, R & D Corp. of Japan, Yokohama.
authors.forename: M
authors.initials: M
authors.lastname: Funaba
authors.forename: T
authors.initials: T
authors.lastname: Murata
authors.forename: E
authors.initials: E
authors.lastname: Murata
authors.forename: K
authors.initials: K
authors.lastname: Ogawa
authors.forename: M
authors.initials: M
authors.lastname: Abe
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: K
authors.initials: K
authors.lastname: Torii
mesh_terms: D000375:Aging; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D015519:Bone Density; D001846:Bone Development / Q000187:drug effects*; D001857:Bone Matrix / Q000502:physiology; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D038681:Follistatin; D006023:Glycoproteins / Q000494:pharmacology* / Q000502:physiology; D006801:Humans; D006937:Hypercholesterolemia / Q000503:physiopathology*; D008297:Male; D010446:Peptide Fragments / Q000378:metabolism; D011347:Procollagen / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D038681:Follistatin; D006023:Glycoproteins; D010446:Peptide Fragments; D011347:Procollagen; C093212:procollagen type II carboxy-terminal peptide; D000469:Alkaline Phosphatase; D002118:Calcium